Login / Signup

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.

Brane GrambozovRomana WassMarkus StanaSabine GerumJosef KarnerGerd FastnerMichael StudnickaFelix SedlmayerFranz Zehentmayr
Published in: Thoracic cancer (2021)
Patients who received immunotherapy and reirradiation lived longer than those who did not receive immunotherapy.
Keyphrases
  • squamous cell carcinoma
  • free survival